Ninety primary melanoma patients were studied to investigate the importance
of adopting the simultaneous use of patent blue dye (PBD) and lymphoscinti
graphy plus gamma detection probe to locate the sentinel node (SN). In tota
l 135 SNs in 105 basins were visualized preoperatively under a gamma camera
after lymphoscintigraphy. When a SN was identified intraoperatively, its r
adioactivity level and colour were verified and documented. Two of the SNs
seen on lymphoscintigraphy were not found. Using PBD 78.52% of the SNs were
identified; 95.5% were identified using the gamma detection probe. Using b
oth methods together 98.5% of the SNs were detected. Twenty-two patients (2
4.4%) had pathologically positive SNs. The surgical learning curve was asse
ssed for the two techniques. The learning curve associated with the methodo
logy was important in finding the SN when using PBD associated with lymphos
cintigraphy, but not when the gamma detection probe was used; we found a st
atistically significant reduction in the percentage of stained SNs found us
ing pan in the initial 14 SNs biopsied compared with the subsequent 121 nod
es. This is important as not all institutions have access to a gamma probe.
The time required to identify each SN was documented and analysed. The dur
ation of the procedure was significantly shorter for stained SNs than for n
on-stained SNs, which support the use of both PBD and the gamma probe. In c
onclusion, SN biopsy should be performed by surgeons and nuclear medicine d
octors in co-operation, both methods being adopted simultaneously to reduce
the percentage of procedure failures, (C) 1999 Lippincott Williams & Wilki
ns.